Third Pole Therapeutics, Inc.
8 News & Press Releases found

Third Pole Therapeutics, Inc. news

Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today a $32M equity investment, from a large medical device innovator.

Bill Athenson, CEO of Third Pole, stated, “We are thrilled to receive this investment, which raises Third Pole Therapeutics’ series B financing and commitments to date to over $85M. I am particularly pleased to welcome this strategi

Dec. 13, 2022
  • eNOfit™, Third Pole’s novel nitric oxide mobile-wearable device designed to provide “on-the-go” treatment for patients suffering from severe COPD and ILD, to enter clinical trials in the second half of this year
  • Funding will support device optimization and clinical trials; Pivotal trial data expected in the second half of 2023

Third Pole Therapeut

Feb. 3, 2022

Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today that it is presenting at the H.C. Wainwright BioConnect 2022 Conference and participating in BIO Partnering at JPM. All events are virtual and scheduled concurrently with the J.P. Morgan 40th

Jan. 5, 2022

Last week the hospital marked a significant milestone – the 175th anniversary of the first public demonstration of ether in surgery, considered one of most game-changing events in medical history. In the spirit of that Oct. 16, 1846 landmark, the MGH, fittingly, shares the story of Courtney Joyce, who was the first patient at the hospital to benefit from inhaled nitric oxide (NO) as a therapy for cystic fibrosis. The medical use of NO represents yet another MGH innovation in anesthesia

Oct. 27, 2021

Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, announced today its Chief Executive Officer Bill Athenson will present at Biotech Showcase 2020 to be held January 13-15, 2020 at the Hilton San Francisco Union Square.

During the presentation Mr. Athenson will discuss Third Pole’s strategy for its investigational device designed to generate nitric oxide from air and electricity (eNO) on-demand and o

Dec. 20, 2019